187 related articles for article (PubMed ID: 8857072)
1. Tyramine pressor sensitivity in healthy subjects during combined treatment with moclobemide and selegiline.
Korn A; Wagner B; Moritz E; Dingemanse J
Eur J Clin Pharmacol; 1996; 49(4):273-8. PubMed ID: 8857072
[TBL] [Abstract][Full Text] [Related]
2. Tyramine pharmacodynamics during combined administration of lazabemide and moclobemide.
Dingemanse J; Hussain Y; Korn A
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):172-7. PubMed ID: 8861736
[TBL] [Abstract][Full Text] [Related]
3. Determination and comparison of the pressor effect of tyramine during long-term moclobemide and tranylcypromine treatment in healthy volunteers.
Berlin I; Zimmer R; Cournot A; Payan C; Pedarriosse AM; Puech AJ
Clin Pharmacol Ther; 1989 Sep; 46(3):344-51. PubMed ID: 2673623
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacology of moclobemide during chronic administration of high doses to healthy subjects.
Dingemanse J; Wood N; Guentert T; Oie S; Ouwerkerk M; Amrein R
Psychopharmacology (Berl); 1998 Nov; 140(2):164-72. PubMed ID: 9860107
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of moclobemide and selegiline on tyramine-evoked mydriasis in man.
Bitsios P; Langley RW; Tavernor S; Pyykkö K; Scheinin M; Szabadi E; Bradshaw CM
Br J Clin Pharmacol; 1998 Jun; 45(6):551-8. PubMed ID: 9663810
[TBL] [Abstract][Full Text] [Related]
6. Interaction between moclobemide and oral tyramine in depressed patients.
Burgess CD; Mellsop GW
Fundam Clin Pharmacol; 1989; 3(1):47-52. PubMed ID: 2714732
[TBL] [Abstract][Full Text] [Related]
7. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
Tiller JW; Maguire KP; Davies BM
Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
Dingemanse J; Kneer J; Wallnöfer A; Kettler R; Zürcher G; Koulu M; Korn A
Clin Neuropharmacol; 1996 Oct; 19(5):399-414. PubMed ID: 8889283
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel monoamine-oxidase inhibitor, moclobemide on the sensitivity to intravenous tyramine and norepinephrine in humans.
Cusson JR; Goldenberg E; Larochelle P
J Clin Pharmacol; 1991 May; 31(5):462-7. PubMed ID: 2050833
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pressor effect of tyramine after treatment with phenelzine and moclobemide in healthy male volunteers.
Simpson GM; Gratz SS
Clin Pharmacol Ther; 1992 Sep; 52(3):286-91. PubMed ID: 1526086
[TBL] [Abstract][Full Text] [Related]
11. Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor.
Korn A; Da Prada M; Raffesberg W; Allen S; Gasic S
J Neural Transm Suppl; 1988; 26():57-71. PubMed ID: 3162952
[TBL] [Abstract][Full Text] [Related]
12. Tyramine pressor sensitivity during treatment with the selegiline transdermal system 6 mg/24 h in healthy subjects.
Azzaro AJ; Vandenberg CM; Blob LF; Kemper EM; Sharoky M; Oren DA; Campbell BJ
J Clin Pharmacol; 2006 Aug; 46(8):933-44. PubMed ID: 16855078
[TBL] [Abstract][Full Text] [Related]
13. Pressor response to tyramine after single 24-hour application of a selegiline transdermal system in healthy males.
Barrett JS; Hochadel TJ; Morales RJ; Rohatagi S; DeWitt KE; Watson SK; Darnow J; Azzaro AJ; DiSanto AR
J Clin Pharmacol; 1997 Mar; 37(3):238-47. PubMed ID: 9089426
[TBL] [Abstract][Full Text] [Related]
14. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine.
Korn A; Da Prada M; Raffesberg W; Gasic S; Eichler HG
J Cardiovasc Pharmacol; 1988 Jan; 11(1):17-23. PubMed ID: 2450251
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of the pressor effect of intravenously administered tyramine during moclobemide treatment.
Zimmer R; Fischbach R; Breuel HP
Acta Psychiatr Scand Suppl; 1990; 360():76-7. PubMed ID: 2248082
[TBL] [Abstract][Full Text] [Related]
16. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
Zimmer R
Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
[TBL] [Abstract][Full Text] [Related]
17. Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramine.
Gieschke R; Schmid-Burgk W; Amrein R
J Neural Transm Suppl; 1988; 26():97-104. PubMed ID: 3283292
[TBL] [Abstract][Full Text] [Related]
18. Tyramine kinetics and pressor sensitivity during monoamine oxidase inhibition by selegiline.
Schulz R; Antonin KH; Hoffmann E; Jedrychowski M; Nilsson E; Schick C; Bieck PR
Clin Pharmacol Ther; 1989 Nov; 46(5):528-36. PubMed ID: 2510962
[TBL] [Abstract][Full Text] [Related]
19. A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
Clarke A; Johnson ES; Mallard N; Corn TH; Johnston A; Boyce M; Warrington S; MacMahon DG
J Neural Transm (Vienna); 2003 Nov; 110(11):1257-71. PubMed ID: 14628190
[TBL] [Abstract][Full Text] [Related]
20. [Hypertensive crises with reversible inhibitors of monoamine oxidases? Results of tyramine interaction studies].
Bieck PR
Psychiatr Prax; 1989 Aug; 16 Suppl 1():25-31. PubMed ID: 2587674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]